Rosoxacin

目录号: PL12165 纯度: ≥98%
Rosoxacin (Acrosoxacin) 是一种口服有效的,具有广谱抗菌活性的喹诺酮类抗生素。Rosoxacin 具有广谱的抗菌活性,抑制革兰氏阴性菌,包括淋病奈瑟氏球菌 (MIC range=0.03-0.125 µg/mL)。Rosoxacin 可用于尿路感染和某些性传播疾病的研究。
CAS No. :40034-42-2
商品编号 规格 价格 会员价 是否有货 数量
PL12165-5mg 5mg ¥887.00 请登录
PL12165-10mg 10mg ¥1485.00 请登录
PL12165-25mg 25mg ¥3125.00 请登录
PL12165-50mg 50mg ¥4475.00 请登录
PL12165-100mg 100mg ¥6315.00 请登录
PL12165-200mg 200mg ¥8515.00 请登录
PL12165-1 mL x 10 mM (in DMSO) 1 mL x 10 mM (in DMSO) ¥851.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Rosoxacin
中文别名
1-乙基-4-氧代-7-(吡啶-4-基)-1,4-二氢喹啉-3-羧酸;罗索沙星
英文名称
Rosoxacin
英文别名
3-Quinolinecarboxylicacid, 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-;1-ethyl-4-oxo-7-(pyridin-4-yl)-1,4-dihydroquinoline-3-carboxylic acid;1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid;ROSOXACIN;1,4-Dihydro-1-ethyl-7-(4-pyridinyl)-4-oxo-3quinolinecarboxylic acid;1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-3-quinolinecarboxylic acid;1-Ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)-3-quinoxalinecarboxylic acid;1-ethyl-1,4-dihydro-4-oxo-7-(pyridin-4-yl)-3-quinolinecarboxylic acid;Acrosoxacin;Eracine;Eradacil;Eradacin;Rosoxacine;Rosoxacino;Rosoxacinum;Roxadyl;Winuron;Rosoxacine [INN-French];Rosoxacino [INN-Spanish];Win 35,213;Rosoxacinum [INN-Latin];1-Ethyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid;1-Ethyl-4-oxo-7-(4-pyridyl)-1,4-dihydroquinoline-3-carboxylic Acid;WIN 35213;3Y1OT3J4;Rosoxacin
Cas No.
40034-42-2
分子式
C17H14N2O3
分子量
294.30
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Rosoxacin (Acrosoxacin) 是一种口服有效的,具有广谱抗菌活性的喹诺酮类抗生素。Rosoxacin 具有广谱的抗菌活性,抑制革兰氏阴性菌,包括淋病奈瑟氏球菌 (MIC range=0.03-0.125 µg/mL)。Rosoxacin 可用于尿路感染和某些性传播疾病的研究。
生物活性
Rosoxacin (Acrosoxacin) is an orally active and broad-spectrum antibacterial quinolone antibiotic. Rosoxacin inhibits Gram-negative bacteria, including N. gonorrhoeae (MIC range=0.03-0.125 μg/mL).Rosoxacin can be used in studies of urinary tract infections and certain sexually transmitted diseases.
性状
Solid
IC50 & Target[1][2]
Quinolone
体外研究(In Vitro)
Rosoxacin (0.03-8 μg/mL; 24 h) shows good susceptibilities to 32 strains of N. gonorrhoeae , with MIC range of 0.03-0.125 μg/mL.
Rosoxacin (0.03-8 μg/mL; 48 h) shows antibacterial activity to C. trachomatis (11 strains), with MICs are 5 μg/mL.
Rosoxacin (0.03-8 μg/mL; 6 days) shows antibacterial activity to U. urealyticum (7 strains), with MIC range of 2-8 μg/mL. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Dobson RA, et al. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum. Antimicrob Agents Chemother. 1980 Nov;18(5):738-40.
溶解度数据
In Vitro: DMSO : 20.83 mg/mL (70.78 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Dobson RA, et al. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum. Antimicrob Agents Chemother. 1980 Nov;18(5):738-40.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2